Matthew Putnins

Matthew Putnins is a Senior Scientist at Genmab, specializing in quantitative pharmacology methods with expertise in population pharmacokinetics, exposure-response modeling, QSP models, and machine learning. Previously, they contributed as a Scientist at Biogen, leading clinical pharmacology study efforts and employing advanced modeling techniques to derive insights for future research. Matthew also held positions at various organizations including Janssen Pharmaceutical Companies and Johnson & Johnson, where they supported projects in diabetes cell therapy and product development. They earned a Master's degree and a Bachelor's degree in Biomedical/Medical Engineering from Stevens Institute of Technology, followed by a PhD from Rutgers University-New Brunswick.